Month: March 2023

Snap One Reports Fiscal Fourth Quarter and Full Year 2022 Results

Written by Customer Service on March 14, 2023. Posted in Earnings Releases And Operating Results.

Full Year 2022 Net Sales of $1.124 Billion Notable Achievements Across Product Suite and Growth Verticals Build on Best-In-Class Integrator Partner Experience Company Introduces Financial Outlook for Fiscal 2023 CHARLOTTE, N.C., March 14, 2023 (GLOBE NEWSWIRE) — Snap One Holdings Corp. (Nasdaq: SNPO) (“Snap One,” the “Company,” “we,” or “our”), a provider of smart living products, services, and software to professional integrators, reported financial results for the fiscal fourth quarter and full year ended December 30, 2022. Fiscal Full Year 2022 and Recent Operational HighlightsContinued investment to deliver industry-leading integrator partner experienceAwarded 17 2022 CE Pro Quest for Quality Awards out of 22 identified sub-categories Ranked a top-three brand 40 times across 62 identified product sub-categories in the 2022...

Yield10 Bioscience Announces Fourth Quarter and Full Year 2022 Financial Results

Written by Customer Service on March 14, 2023. Posted in Earnings Releases And Operating Results.

-Executing strategy to build supply chain alliances for the production of low-carbonintensity Camelina feedstock oil for the biofuels market-Advancing development of herbicide tolerant Camelina varieties-Accelerating development of omega-3 Camelina -Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate update WOBURN, Mass., March 14, 2023 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today reported financial results for the fourth quarter and full year ended December 31, 2022. “Yield10 is building a diverse Camelina products business based on our differentiated technology capabilities in this promising crop,” said Oliver Peoples, Ph.D., President and Chief Executive Officer...

Pardes Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Written by Customer Service on March 14, 2023. Posted in Earnings Releases And Operating Results.

Data from ongoing Phase 2 trial evaluating pomotrelvir (formerly known as PBI-0451) for the treatment of COVID-19 expected in the coming weeks Cash to fund operations for the next twelve months CARLSBAD, Calif., March 14, 2023 (GLOBE NEWSWIRE) — Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage biopharmaceutical company developing pomotrelvir as a potential stand-alone novel direct-acting, oral antiviral drug candidate for the treatment of COVID-19, today reported financial results for the fourth quarter and full year ended December 31, 2022 and provided a business update. “We are greatly encouraged by the progress made in our ongoing Phase 2 study evaluating pomotrelvir for the treatment of COVID-19, and we continue to believe in its potential to fulfill the unmet demand for a stand-alone, oral antiviral treatment that...

Rafael Holdings Reports Second Quarter Fiscal 2023 Financial Results

Written by Customer Service on March 14, 2023. Posted in Earnings Releases And Operating Results.

NEWARK, N.J., March 14, 2023 (GLOBE NEWSWIRE) — Rafael Holdings, Inc. (NYSE: RFL), today reported its second quarter fiscal 2023 financial results for the three months and six months ended January 31, 2023. “Our strong balance sheet allows us to continue to fund our pipeline assets and explore selective strategic business development opportunities, which potentially could improve the lives of patients and generate value for our shareholders,” said Bill Conkling, CEO of Rafael Holdings. Rafael Holdings, Inc. Second Quarter Fiscal Year 2023 Financial Results As of January 31, 2023, we had cash, cash equivalents and marketable securities of $88.9 million. For the three months ended January 31, 2023, we incurred a net loss from continuing operations of $3.3 million, or $0.13 per share. For the same period in the prior year, we incurred...

Oxurion Provides Update on Recruitment for KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema and Announces Board Changes

Written by Customer Service on March 14, 2023. Posted in Public Companies.

Oxurion Provides Update on Recruitment for KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edemaand Announces Board Changes Trial has now enrolled more than two-thirds of total subjectsBuilds upon Interim Analysis Outcome in DecemberTop-line Data Anticipated in Q4 2023 Leuven, BELGIUM, Boston, MA, US – March 14, 2023 – 9:00 pm CET – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, announced today that it has enrolled more than two-thirds of the planned total enrollment in its KALAHARI Phase 2, Part B clinical trial (KALAHARI trial). The KALAHARI trial is evaluating Oxurion’s novel plasma kallikrein (PKal) inhibitor THR-149 as a potential treatment for patients with...

Link Reservations, Inc. (LRSV) Announces Acquisition of Global Enterprises & Logistics, Inc.

Written by Customer Service on March 14, 2023. Posted in Mergers And Acquisitions.

MIAMI, March 14, 2023 (GLOBE NEWSWIRE) — Link Reservations Inc. (OTC PINK: LRSV) (the “Company”) is pleased to announce today, that further to the Letter of Intent (“LOI”) dated June 6th, 2022 with Global Enterprises and Logistics, Inc. (”Global”), as disclosed in the Supplemental Disclosure filed with OTC Markets Group March 9th, 2023, the Company has successfully completed the acquisition of Global Enterprises & Logistics, Inc., as a wholly owned subsidiary of the Company through a Share Exchange Agreement (“SEA”) dated March 3rd, 2023. Global Enterprises and Logistics, Inc. is a provider of refrigerated freight forwarding and individualized logistics for a wide spectrum of clients in the wholesale and retail food industry, including the hospitality industry, both of which rely on the timely delivery of regular and recurring...

Nokia Corporation: Repurchase of own shares on 14.03.2023

Written by Customer Service on March 14, 2023. Posted in Public Companies.

Nokia CorporationStock Exchange Release14 March 2023 at 21:00 EET Nokia Corporation: Repurchase of own shares on 14.03.2023 Espoo, Finland – On 14 March 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 293,931 4.38CEUX 18,168 4.41AQEU 2,500 4.41TQEX 2,401 4.41Total 317,000 4.38* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU)...

Nano Dimension’s Chairman & CEO’s Video Message to Stratasys Shareholders – A Potential Nano-Stratasys Merger Will Supply:

Written by Customer Service on March 14, 2023. Posted in Public Companies.

· Cash for Stratasys shareholders, unattainable otherwise · Attractive shareholder value and share price for Nano shareholders Waltham, Mass., March 14, 2023 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional polymer, metal & ceramic Additive Manufacturing (“AM”) 3D printers, released a video in which Yoav Stern, Chairman and Chief Executive Officer of the Company, outlines why and how Stratasys Ltd. (“Stratasys”) and Nano Dimension together are such a powerful combination that will benefit all shareholders. Mr. Stern outlines the value creation mechanisms for Stratasys shareholders by speaking to points across the business, including strategy, customers and go-to-market, product development...

Dominion Lending Centres Inc. Announces Q4-2022 Earnings Release Date

Written by Customer Service on March 14, 2023. Posted in Public Companies.

VANCOUVER, British Columbia, March 14, 2023 (GLOBE NEWSWIRE) — Dominion Lending Centres Inc. (TSX:DLCG) (“DLCG” or the “Corporation”) is pleased to announce that it will release its financial results for the three months and year ended December 31, 2022, on March 28, 2023, after the market close. About Dominion Lending Centres Inc. The DLC Group is Canada’s leading network of mortgage professionals. The DLC Group operates through Dominion Lending Centres and its three main subsidiaries, MCC Mortgage Centre Canada Inc., MA Mortgage Architects Inc. and Newton Connectivity Systems Inc., and has operations across Canada. The DLC Group’s extensive network includes ~8,200 agents and ~540 locations. Headquartered in British Columbia, the DLC Group was founded in 2006 by Gary Mauris and Chris Kayat. Contact information for the Corporation...

ECN Capital Declares First Quarter 2023 Preferred Share Dividend

Written by Customer Service on March 14, 2023. Posted in Dividend Reports And Estimates.

TORONTO, March 14, 2023 (GLOBE NEWSWIRE) — ECN Capital Corp. (TSX: ECN) (“ECN Capital” or the “Company”) announced today that the Company’s Board of Directors has authorized and declared a quarterly dividend of C$0.4960625 per outstanding Cumulative 5-Year Rate Reset Preferred Share, Series C (TSX: ECN.PR.C) to be paid on March 31, 2023 to shareholders of record as of close of business on March 21, 2023. This dividend is designated to be an eligible dividend for purposes of section 89(1) of the Income Tax Act (Canada). About ECN Capital Corp. With originated assets of more than US$14 billion, ECN Capital Corp. (TSX: ECN) is a leading provider of business services to North American based banks, credit unions, life insurance companies, pension funds and institutional investors (collectively our “Partners”). ECN Capital originates,...

Month: March 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals